Frequently Asked Questions

Fountain Health is a multidisciplinary medical practice based in New York City that brings mental health, hormonal health, weight and metabolic care, sexual health, nutrition, fitness, cognitive health, and longevity-focused care into one coordinated model. Unlike traditional care, where patients are often sent to multiple specialists who work separately, Fountain is designed around one team working from the same clinical picture. Depending on your needs, care may involve physicians, mental health clinicians, nutrition support, fitness guidance, laboratory testing, body composition, and other relevant assessments. Fountain also combines an in-person NYC medical practice with telehealth and prescription treatments, including compounded medications when appropriate. The goal is to make comprehensive care easier to access while keeping it coordinated, medically supervised, and personalized over time.

Fountain Health provides care across mental health, IV ketamine, hormonal health, weight and metabolic health, sleep, nutrition and fitness, and longevity. Depending on your needs, your care may involve psychiatry, psychology, medical evaluation, medication management, laboratory testing, nutrition support, or performance-focused care. What makes the model different is that these areas are not treated as completely separate problems. Sleep can affect mood and cognition; hormones can influence energy and sexual health; metabolic health and nutrition can affect both physical and mental performance. When more than one area is relevant, Fountain’s specialists can work together around the same goals and clinical picture so that care is coordinated rather than fragmented.

Yes. Fountain is a New York City medical practice with a physical clinic, and we also provide telehealth care to eligible patients in the states where our clinicians are licensed. That means you can access Fountain in the way that best fits your care. Services that require in-person evaluation or treatment are provided at our NYC clinic, while many consultations, follow-up visits, and prescription treatments, including compounded medications, can be managed virtually when appropriate. What makes Fountain different is that virtual care is still connected to the same multidisciplinary clinical team and broader treatment model. Whether you see us in person or through telehealth, the goal is the same: understand the full picture, choose the right treatment, and coordinate your care over time.

Your care starts with understanding your symptoms, medical history, previous treatments, goals, lifestyle, and other factors that may be affecting how you feel and function. Depending on your needs, your team may also use laboratory testing, validated assessments, wearable data, or other diagnostics. From there, we build an evolving care plan around what is most relevant to you. As your symptoms, biomarkers, goals, and response change, your treatment can change with you rather than staying fixed around a one-size-fits-all protocol.

Care does not stop after the initial appointment. Your team follows how you are responding, reviews relevant results, helps address side effects or obstacles, and adjusts treatment when needed. Depending on your care plan, this may include follow-up visits, repeat testing or assessments, communication with your care team, and collaboration between Fountain specialists to make sure your care stays coordinated over time.

Yes. Your Fountain providers can work from a shared understanding of your health so that different parts of your care are not managed in isolation. For example, anxiety may overlap with poor sleep, hormonal changes, nutrition, or metabolic health. When multiple specialists are involved, they can coordinate their perspectives and recommendations into a more unified treatment plan.

No. You can contact Fountain directly, and our team can help determine the right place to start based on your concerns and goals. If you already have a psychiatrist, therapist, primary care physician, or another specialist, Fountain can also collaborate with them, with your permission, to help keep your care coordinated.

Cost varies depending on the type of care, the specialists involved, and whether testing, medications, or additional services are recommended. Before you begin, our team will explain the expected costs and what is included so you can understand the financial commitment upfront and make an informed decision about your care.

Fountain is an out-of-network practice, but our team is here to help make the reimbursement process as easy as possible. For eligible services, we can prepare and submit a superbill on your behalf and help guide you through the steps with your insurance company. Reimbursement depends on your individual out-of-network benefits, deductible, and plan rules, but we will help with the documentation and process so you are not navigating it alone.

New York, New Jersey, Connecticut, Pennsylvania, Florida, California, and Texas

Town & Country Compounding Pharmacy, 535 East Crescent Ave, Ramsey, NJ 07446. Call or Text: (201) 447-2020 | Toll-Free: (800) 850-2101

Compounded medications are not FDA-approved finished drug products. They are prepared by licensed compounding pharmacies based on a prescription when a particular formulation, dose, or delivery method is clinically appropriate for an individual patient. At Fountain, the decision to use a compounded medication begins with a clinician evaluating whether the treatment is appropriate for you. We also carefully select our pharmacy partners and review their quality standards, testing, and documentation as part of our clinical process. The goal is not simply to offer compounded medications, but to use them thoughtfully when they fit the patient's broader treatment plan.

You do not need to diagnose yourself before contacting Fountain. Start by telling us what you are experiencing, what has changed, and what you want to improve. Our team can help determine the most appropriate place to start. If your symptoms involve more than one area of health, additional Fountain specialists can become involved as needed so you are not left trying to coordinate the different pieces yourself.

Your first appointment is designed to understand the broader clinical picture rather than focusing only on a single symptom. Your provider will review your concerns, medical history, medications, previous treatments, lifestyle, and goals for care. Depending on why you are coming to Fountain, the next step may include treatment, additional testing, another specialist, or a combination of approaches. The goal is to leave with a clearer understanding of what may be contributing to how you feel and what should happen next.

That is common. Fatigue, brain fog, weight changes, poor sleep, low mood, sexual symptoms, and changes in performance can have overlapping medical, hormonal, metabolic, nutritional, psychological, or sleep-related contributors. Fountain is structured so the relevant clinicians can work from the same clinical picture and coordinate recommendations rather than treating each symptom as a completely separate problem.

No. Testing should have a clinical purpose. Some patients benefit from laboratory evaluation because their symptoms, medical history, or treatment make additional information useful. Others may not need extensive testing. We use testing when the results can help clarify the clinical picture, guide a treatment decision, establish a baseline, or monitor how something is changing over time.

Yes. You do not need to replace your existing care team to receive treatment at Fountain. With your permission, Fountain can coordinate with outside physicians, psychiatrists, therapists, and other clinicians when doing so would improve continuity of care. Our goal is to reduce fragmented care, not create another disconnected provider for you to manage.

Appointment frequency depends on what you are being treated for, where you are in the treatment process, and how closely something needs to be monitored. Someone beginning a new medication or treatment may initially need more frequent follow-up than someone whose care is stable. As your condition and treatment evolve, the frequency of visits can change as well.

We look at whether the treatment is producing the outcome we expected. That may include your symptoms, side effects, daily functioning, laboratory results, body composition, validated assessments, or other measures depending on your care. A treatment may be adjusted when progress is not occurring as expected, side effects emerge, new information becomes available, or your goals change. The question is not simply whether you are “on treatment,” but whether that treatment is continuing to earn its place in your care plan.

Many consultations, follow-up visits, and treatment-management appointments can be provided through telehealth when clinically appropriate. Other services require in-person care, including IV ketamine and certain examinations, testing, or procedures. Your care team can help determine which parts of your treatment can be handled virtually and when an in-person visit is appropriate.

Fountain provides care for depression, anxiety, trauma-related symptoms, ADHD and attention concerns, OCD and intrusive thoughts, bipolar and other mood disorders, substance-use concerns, and persistent symptoms that have not improved enough with previous treatment. Care may include psychiatry, psychology, medication management, psychotherapy, IV ketamine when appropriate, and evaluation of relevant medical factors. The goal is to understand the full clinical picture and build a coordinated plan rather than treating each symptom separately.

Traditional psychiatric care often focuses primarily on diagnosis and medication. Fountain combines psychiatry and psychology with a broader medical team when the clinical picture calls for it. For example, persistent depression, anxiety, fatigue, brain fog, or poor concentration may sometimes overlap with sleep, medications, hormonal health, metabolic health, nutrition, or other medical concerns. Fountain can evaluate these areas within one coordinated practice rather than sending the patient through a series of disconnected referrals. Fountain’s multidisciplinary model is built around psychiatry, internal medicine, psychology, neuropsychology, nutrition and fitness, and relevant biological assessment when indicated.

Yes. Fountain works with patients whose depression has not improved enough with standard treatments such as antidepressants or psychotherapy. Treatment begins with a psychiatric and medical evaluation to understand previous treatments, current symptoms, medications, and other factors that may be affecting recovery. Depending on the patient, the plan may include medication changes, psychotherapy, physician-led IV ketamine, or evaluation of relevant sleep, hormonal, metabolic, nutritional, or medical contributors.

Yes. Fountain is built around co-care and can complement the clinicians you already trust. Some patients continue therapy with an outside therapist while Fountain provides psychiatry, medication management, IV ketamine, or medical evaluation. With your permission, Fountain can coordinate with your existing clinicians so treatment plans remain aligned rather than creating another disconnected part of your care.

Yes. Fountain provides physician-led psychiatric evaluation and medication management for patients who may benefit from starting, changing, simplifying, or reassessing psychiatric medications. Medication decisions are based on your diagnosis, symptoms, previous response, side effects, medical history, and other medications you may be taking. Medication is one treatment option within the broader care plan, not automatically the first or only intervention.

Difficulty focusing does not always mean ADHD. Anxiety, depression, poor sleep, medications, stress, hormonal changes, and other health issues can sometimes produce similar symptoms. Fountain evaluates the history and pattern of symptoms rather than relying on a single complaint such as poor concentration. When more detailed cognitive assessment is appropriate, neuropsychological expertise can also be incorporated into the evaluation.

Yes. Depression and anxiety frequently overlap, and symptoms can also interact with sleep, trauma, stress, attention, substance use, and physical health. Fountain looks at how the symptoms fit together rather than forcing every concern into a separate diagnosis. Treatment is then built around the overall clinical picture and may combine psychotherapy, medication, behavioral changes, medical evaluation, or other treatments when appropriate.

That is common. Fatigue, brain fog, poor sleep, low motivation, anxiety, mood changes, and difficulty concentrating can overlap across psychiatric, cognitive, and medical conditions. Fountain is particularly well suited to these more complex presentations because the relevant clinicians can evaluate different parts of the picture and bring the findings together into one coordinated plan. That multidisciplinary model is specifically designed for symptoms that do not sit neatly within one specialty.

Fountain does not treat ketamine as simply the delivery of an infusion. IV ketamine sits within a broader psychiatric and medical care model that begins with understanding the patient’s symptoms, treatment history, medical history, medications, and overall clinical picture. Treatment includes physician-led evaluation, individualized dosing, continuous clinical monitoring, structured follow-up, symptom measurement, and integration support when appropriate. If other psychiatric, medical, sleep, hormonal, metabolic, nutritional, or behavioral factors appear relevant, those can be evaluated as part of the broader Fountain care model rather than treating ketamine in isolation.

Fountain’s proprietary protocol is an individualized clinical approach to how ketamine dosing is selected and adjusted throughout treatment. We do not view a patient’s body weight as enough information to determine the entire treatment plan. Weight is one consideration, but our clinicians also look at the condition being treated, how symptoms are presenting, medical and psychiatric history, previous treatment response, medications, sensitivity to treatment, tolerability, and the patient’s response to prior infusions. The dose can evolve as we learn how that individual patient responds.

Yes. Two patients may be receiving IV ketamine but have very different clinical presentations and treatment goals. A patient whose primary concern is treatment-resistant depression may not be approached exactly the same way as someone whose symptoms are dominated by severe anxiety, trauma-related distress, intrusive thoughts, or another psychiatric presentation. Fountain considers the condition being treated and the individual patient when determining the treatment approach, rather than applying the same standardized infusion to everyone.

Weight is useful, but it does not tell us everything about how an individual patient may respond to ketamine. For example, two patients may both weigh 130 pounds, but one may be 5'10" and the other 5'1". They can differ significantly in body composition, physiology, medication use, treatment history, sensitivity to medications, and the condition being treated. Even though a simple weight-based calculation might initially treat them similarly, their clinical response may be very different. Fountain therefore uses weight as one input within a broader dosing approach. We also consider the patient’s psychiatric presentation, medical history, medications, prior treatment response, tolerability, and what we observe during and between infusions. The treatment can then evolve across the series based on how that individual patient actually responds. Two people can weigh the same and still need very different treatment approaches.

No. Ketamine is one potential intervention within a larger treatment plan. For some patients, the most important next step may also involve medication management, psychotherapy, sleep, nutrition, hormonal or metabolic evaluation, or another part of their health. Fountain’s multidisciplinary model allows the ketamine team to consider those factors rather than assuming an infusion alone will address everything contributing to how a patient feels.

We do not judge success solely by how a patient feels during an infusion. Fountain follows symptoms and clinical progress across the treatment series and uses structured symptom measurement alongside the patient’s experience and clinician assessment. We look for meaningful changes in areas such as mood, anxiety, functioning, emotional flexibility, sleep, engagement in daily life, and other symptoms relevant to the individual patient. Treatment can then be reassessed based on whether it is producing meaningful benefit.

Yes. Fountain strongly supports co-care when it benefits the patient. You do not need to leave an established therapist, psychiatrist, or other clinician to receive IV ketamine at Fountain. With your permission, our team can coordinate with your existing providers, share relevant treatment information, and help ensure that ketamine fits into the care you are already receiving rather than becoming a separate treatment silo.

Yes, when clinically appropriate. Ketamine-assisted psychotherapy (KAP), psychological integration, guided reflection, or coordination with an existing therapist can be incorporated into treatment depending on the patient’s needs. The purpose of integration is to help patients make use of changes or insights that may emerge during treatment and connect them to the therapeutic work taking place outside the infusion room. Fountain can provide this support internally or coordinate with an existing therapist. Fountain’s program specifically includes KAP and integration as part of the broader treatment model when appropriate.

Fountain focuses on IV ketamine because it is the most extensively studied route of ketamine for depression and other mood disorders and gives our clinical team the greatest precision and control over treatment. IV administration allows us to know exactly how much ketamine is being delivered and control the rate of the infusion. More importantly, it supports the way Fountain approaches dosing. We do not simply calculate a dose from body weight and repeat it. Our physicians consider the condition being treated, how symptoms are presenting, medical and psychiatric history, medications, tolerability, and the patient’s response to previous infusions. The treatment can then evolve throughout the series as we learn how that individual patient responds. Other routes can be appropriate in different settings, but Fountain has deliberately built its program around physician-led IV ketamine because it allows us to combine precise delivery, individualized dosing, continuous monitoring, and ongoing clinical decision-making within one structured protocol.

The goal is not to keep every patient on the same treatment schedule indefinitely. After the initial series, Fountain evaluates how much the patient improved, how durable that improvement has been, and what ongoing care is appropriate. Some patients may benefit from maintenance infusions, while others may go longer periods without additional ketamine. Follow-up may also focus on psychotherapy, psychiatric medication management, medical contributors, sleep, nutrition, exercise, or other parts of the care plan. Fountain’s typical initial course is individualized, with maintenance based on response and clinical need rather than a rigid universal schedule.

Weight management should begin with more than a prescription. Fountain reviews your medical history, weight history, medications, metabolic health, previous treatment attempts, symptoms, and relevant risk factors before deciding whether medication is appropriate. Depending on your clinical picture, this may also include laboratory testing, body-composition assessment, and evaluation of hormonal or metabolic factors that could influence treatment.

Testing is individualized based on your health history and treatment plan. Fountain may evaluate markers related to blood sugar, cholesterol, liver and kidney function, thyroid health, nutritional status, hormones, or other areas when clinically relevant. Repeat testing may be used during treatment to monitor safety, track metabolic changes, and determine whether the care plan should be adjusted.

The number on the scale does not show whether you are losing fat, muscle, or both. Fountain uses body-composition assessment, including DEXA when appropriate, to understand how your body is changing during treatment. This helps us focus on fat loss while protecting muscle, strength, and long-term metabolic health.

Yes. Weight can be influenced by factors such as insulin resistance, thyroid function, menopause, hormonal changes, sleep, medications, and changes in muscle mass or activity. When the clinical picture suggests another factor may be contributing, Fountain can evaluate it as part of the same weight-management plan rather than treating weight as an isolated problem.

Medical weight management requires ongoing follow-up, particularly when prescription medication is involved. Fountain clinicians monitor your response, side effects, weight and body-composition changes, laboratory results when relevant, and overall health. The treatment plan can then be adjusted over time rather than relying on a fixed prescription or dose.

Dose changes are based on more than how quickly the scale is moving. Your clinician considers appetite, side effects, weight trajectory, body composition, metabolic health, treatment goals, and how well you are tolerating the medication. Fountain generally favors thoughtful titration rather than increasing medication simply because a higher dose is available.

Muscle supports strength, physical function, metabolic health, and healthy aging. During significant weight loss, some lean mass can be lost along with fat. That is why Fountain evaluates weight loss in the context of body composition, nutrition, protein intake, and resistance training. The goal is not simply to weigh less, but to improve overall health and body composition.

Weight is only one measure of progress. Fountain also looks at the broader medical picture, which may include blood sugar, lipids, blood pressure, body composition, energy, strength, sleep, and other relevant markers. If the scale is changing but the rest of your health is not improving as expected, we reassess the plan and look for other factors that may need attention.

Your clinician starts with your symptoms, medical history, medications, menstrual or reproductive history when relevant, sleep, energy, body-composition changes, sexual health, and other factors that may help explain what you are experiencing. From there, we determine which laboratory testing or additional evaluation is actually useful. The goal is to understand the pattern behind the symptoms rather than begin with a predetermined hormone treatment.

There is no single hormone panel that is appropriate for everyone. Testing depends on your symptoms, age, medical history, sex, menstrual or menopause status, medications, and the clinical question being investigated. Depending on the situation, Fountain may evaluate thyroid function, testosterone and related hormones, estrogen-related markers, metabolic health, nutritional status, or other relevant measurements. Results are interpreted alongside your symptoms rather than in isolation.

A laboratory result can fall within a reference range without fully explaining how you feel. Hormones also change with age, time of day, menstrual cycle, sleep, stress, medications, and other health factors. Fountain looks at trends, symptoms, timing of testing, and the broader clinical picture rather than deciding that a single “normal” result automatically rules out a hormonal issue.

Perimenopause is often identified from the pattern of symptoms and menstrual changes rather than one definitive blood test. Hormone levels can vary considerably during the transition. Fountain considers cycle changes, hot flashes, sleep, mood, cognition, body composition, sexual health, medical history, and targeted testing when useful to determine whether the overall picture is consistent with perimenopause.

Low testosterone should not be diagnosed from fatigue or low libido alone. Fountain considers symptoms together with appropriately timed laboratory testing and looks at factors that can affect testosterone, including sleep, metabolic health, medications, body composition, stress, and other hormonal signals. The goal is to understand why testosterone may be low and whether it is actually contributing to the symptoms.

They can. Thyroid dysfunction may affect energy, weight, concentration, mood, temperature tolerance, menstrual patterns, and other areas of health. Because these symptoms can also come from sleep problems, mental-health conditions, medications, nutritional issues, metabolic health, or other causes, Fountain evaluates thyroid function as part of the broader clinical picture rather than assuming it explains everything.

Hormonal symptoms rarely exist in complete isolation. Fatigue, poor sleep, brain fog, low libido, weight changes, mood changes, and reduced recovery can overlap across endocrine, metabolic, psychiatric, nutritional, and sleep-related conditions. Fountain’s model allows those areas to be considered together so patients are not sent from specialist to specialist with no one connecting the findings. That coordinated approach is central to Fountain’s broader care model.

We follow both objective findings and how you are actually feeling and functioning. Depending on the clinical question, that may include symptoms, laboratory values, menstrual patterns, sleep, sexual health, energy, strength, weight or body composition, and other relevant measures. A better laboratory number is not automatically a successful outcome. The goal is meaningful improvement in the problem that brought you in while keeping the overall plan medically appropriate.

An annual physical is important, but it often focuses on whether there is a current medical problem or whether standard screening is up to date. Longevity medicine takes a longer view. Fountain looks at cardiovascular and metabolic health, body composition, muscle and bone health, hormones, sleep, cognition, nutrition, family history, and other factors that may influence how you age. The goal is to identify areas worth addressing earlier and follow them over time, not simply confirm that nothing is wrong today.

There is no single age when longevity care should begin. Many patients start when they want a clearer understanding of their current health, notice changes in energy or performance, develop a stronger family history concern, or simply want to be more proactive about aging. The earlier value is often establishing a meaningful baseline so changes in metabolic health, cardiovascular risk, muscle, cognition, hormones, or other areas can be recognized over time.

A thoughtful longevity evaluation should begin with your medical history, family history, medications, lifestyle, symptoms, and goals. Depending on your individual risk profile, Fountain may also look at cardiovascular and metabolic markers, body composition, muscle and bone health, hormonal health, sleep, cognitive function, nutrition, and preventive screening. The evaluation is individualized rather than built around one universal testing panel.

Sometimes. Conditions such as insulin resistance, cardiovascular risk, loss of muscle mass, changes in bone health, or certain metabolic abnormalities can develop before someone feels unwell. Longevity care uses medical history, appropriate screening, physical measures, and targeted testing to identify risks that may be worth addressing earlier. It is not about predicting every future illness, but about making better preventive decisions with the information available now.

Weight alone gives an incomplete picture of health. Muscle mass and strength are closely connected to mobility, metabolic health, physical function, and independence as we age. Fountain may use body-composition assessment alongside nutrition and strength evaluation to understand whether a patient is maintaining muscle and healthy body composition over time. The goal is not simply to weigh less, but to remain strong and functional.

Brain health is part of healthy aging, not a separate issue. Changes in memory, attention, processing speed, sleep, mood, or executive function can sometimes overlap with medical, psychiatric, metabolic, hormonal, or nutritional factors. When appropriate, Fountain can incorporate cognitive assessment alongside the broader medical picture so cognitive concerns are evaluated in context rather than automatically treated as an isolated neurological problem.

Yes. Family history can influence how clinicians think about cardiovascular disease, diabetes, certain cancers, cognitive decline, and other health risks. Fountain considers family history alongside your own medical history, current health markers, age, and other risk factors to determine which areas deserve closer attention and whether additional screening or preventive evaluation may be appropriate.

Longevity care should be measurable over time. Depending on the patient, Fountain may follow laboratory markers, blood pressure, body composition, strength, sleep, cognitive measures, metabolic health, symptoms, or other clinically relevant indicators. The purpose is not to collect more data for its own sake. It is to establish a baseline, make targeted changes, re-measure what matters, and adjust the plan based on whether your health is actually improving.

Sleep duration is only one part of sleep quality. You can spend seven or eight hours in bed and still have fragmented sleep, sleep apnea, restless legs, circadian disruption, medication effects, anxiety, depression, hormonal changes, or other medical issues that prevent restorative sleep. Fountain looks at both the sleep complaint and the broader clinical picture to understand why you are not waking up refreshed.

Snoring is common, but sleep apnea can also show up as morning headaches, dry mouth, waking frequently, daytime fatigue, poor concentration, irritability, or feeling unrefreshed despite adequate time in bed. Some people with sleep apnea do not fit the stereotypical profile. If the history raises concern, a clinician may recommend formal sleep testing. The goal is to identify what is actually disrupting your sleep, treat the relevant contributors, and then follow whether your sleep and daytime functioning are improving.

Frequent nighttime waking can have many causes, including insomnia, sleep apnea, anxiety, alcohol, medications, hormonal changes, pain, urinary symptoms, circadian issues, or other medical conditions. Fountain evaluates the pattern of the awakenings rather than assuming every case is simply “stress” or primary insomnia.

Yes. Poor or fragmented sleep can affect attention, memory, emotional regulation, energy, and mood. Because these symptoms can also come from psychiatric, hormonal, metabolic, nutritional, or other medical issues, Fountain looks at sleep as one part of the broader clinical picture rather than treating it in isolation.

Insomnia generally involves difficulty falling asleep, staying asleep, or returning to sleep despite having the opportunity to rest. Sleep apnea involves repeated interruptions in breathing during sleep, which can fragment sleep even when you do not remember waking up. A person can also have both conditions at the same time, which is one reason a careful sleep evaluation matters.

The evaluation begins with your sleep schedule, symptoms, medical and psychiatric history, medications, lifestyle, and daytime functioning. Depending on the clinical picture, Fountain may also consider sleep apnea risk, circadian rhythm, restless legs, mood, hormones, metabolism, medications, or other medical contributors. If a sleep study or additional testing is appropriate, the next step is guided by what the evaluation suggests.

Yes. Hormonal changes during perimenopause and menopause can coincide with hot flashes, night sweats, changes in sleep continuity, and difficulty staying asleep. Fountain considers hormonal health alongside sleep, mood, medications, and other medical factors rather than assuming all sleep disruption has a single cause.

We look beyond whether you are simply spending more time in bed. Progress may include fewer awakenings, better daytime energy, improved concentration, reduced sleepiness, better mood, improved sleep quality, or changes in sleep-study findings when relevant. The goal is restorative sleep and better daytime function, not just a higher number of hours.

Nutrition and physical activity affect far more than weight. They can influence metabolic health, cardiovascular health, muscle and bone, sleep, energy, cognition, physical function, and mental health. For example, inadequate nutrition can contribute to fatigue and poor recovery, while regular exercise can support mood, sleep, metabolic health, and physical resilience. At Fountain, nutrition and fitness are therefore considered part of the broader health picture rather than separate lifestyle recommendations.

We do not treat nutrition and exercise as generic advice to “eat better and work out more.” Your needs depend on your metabolism, body composition, medical history, hormones, sleep, medications, mental health, current fitness, and the goals you are trying to achieve. Fountain’s nutrition and fitness care works alongside internal medicine, hormonal care, psychiatry, sleep medicine, and other parts of your treatment when relevant. The goal is for the different specialists to work from the same clinical picture rather than giving you disconnected recommendations. Your plan is then adjusted based on how your body is actually responding.

There is no single diet that is right for everyone. Your nutrition plan should reflect your energy needs, body-composition goals, activity level, medical history, food preferences, and ability to follow it consistently. Depending on your goals, we may look at protein, carbohydrates, fats, fiber, micronutrients, meal timing, hydration, and total energy intake. The objective is not simply to restrict food, but to give your body what it needs to support energy, metabolic health, training, recovery, and the results you are working toward.

Protein needs vary based on body size, age, activity level, overall health, calorie intake, and whether your goal is fat loss, muscle gain, maintenance, or recovery. Someone who is resistance training or actively losing weight may require a different protein target than someone who is less active. Rather than using one number for everyone, your nutrition team can establish a target based on your individual needs and adjust it as your goals and body composition change.

Yes, in some circumstances. Whether you can gain muscle while losing fat depends on factors such as your starting body composition, training experience, calorie intake, protein intake, recovery, hormones, and resistance-training program. That is why the scale alone can be misleading. Someone may be losing body fat while preserving or gaining lean mass without seeing a dramatic change in total body weight. We focus on body composition and function, not simply making the number on the scale lower.

For most people, both have an important role. Resistance training helps build or preserve muscle, strength, bone health, and physical function. Aerobic exercise supports cardiovascular fitness, metabolic health, endurance, and overall health. The right balance depends on your goals, health, fitness level, schedule, and ability to recover. The objective is not to maximize every type of exercise at once, but to build a program that produces the adaptations you actually need.

Not necessarily. Supplements are most useful when they address an identified deficiency, dietary gap, specific medical need, or evidence-supported goal. When laboratory testing or your clinical history suggests that something may be missing, targeted supplementation can be incorporated into the broader plan. We prefer to identify why a supplement is being used and what we expect it to accomplish rather than building large supplement regimens without a clear purpose.

We look at more than weight. Depending on your goals, progress may be assessed through body composition, strength, cardiovascular fitness, laboratory markers, energy, sleep, symptoms, recovery, and how you are functioning day to day. Those measurements give us a baseline and help show whether the plan is actually producing the intended change. Fountain’s broader model is built around measuring across systems, intervening, and then re-measuring against your own starting point rather than assuming the first plan should remain unchanged indefinitely.

A psychiatrist is a physician who specializes in diagnosing and treating mental health conditions. Because psychiatrists are medical doctors, they can prescribe medication while also considering how medical conditions, other medications, substances, sleep, and physical health may be affecting psychiatric symptoms. Psychiatric care is not limited to prescribing. It can also include diagnostic evaluation, treatment planning, risk assessment, monitoring response to treatment, and determining when psychotherapy, medical evaluation, or another intervention may be appropriate.

We do not assume that every mental health symptom should automatically lead to another psychiatric medication. Symptoms such as low mood, anxiety, fatigue, poor concentration, or sleep disruption can sometimes reflect a combination of psychiatric, medical, hormonal, metabolic, nutritional, and behavioral factors. Fountain’s model allows psychiatry to work alongside psychology, internal medicine, hormonal care, nutrition, sleep medicine, and other specialties when relevant. The goal is to understand the broader clinical picture and determine which interventions actually belong in your treatment plan rather than treating each symptom in isolation.

There is no single antidepressant that is best for everyone. The choice depends on your symptoms, diagnosis, previous medication experiences, other medications and medical conditions, side-effect concerns, sleep, weight, sexual health, and personal preferences. Your clinician may also consider how different symptoms fit together. For example, someone struggling primarily with low energy and motivation may require a different approach from someone whose depression is accompanied by severe anxiety or insomnia. The goal is to choose treatment around the individual rather than simply starting the same medication for every patient.

Antidepressants generally do not produce their full effect immediately. Some changes may appear earlier, while meaningful improvement in mood, anxiety, motivation, or functioning can take several weeks. Your clinician should establish what symptoms you are trying to improve and follow your response over time. That makes it easier to determine whether the medication is beginning to help, whether more time is appropriate, or whether the treatment plan should be adjusted.

A medication not working is useful clinical information. The next step is not necessarily to simply move to another medication. Your clinician may revisit the diagnosis, determine whether the dose and duration were adequate, review side effects and adherence, consider other medications or medical contributors, add psychotherapy, change medications, or consider other treatments such as interventional psychiatry when appropriate. Especially after several unsuccessful treatments, the question becomes not only “What medication should we try next?” but “Is there something about the clinical picture we have not adequately addressed?”

Treatment-resistant depression generally refers to depression that has not improved adequately despite appropriate treatment attempts, although definitions can vary across clinical practice and research. At Fountain, we look beyond the label. We review which treatments were actually tried, the doses and duration, adherence, side effects, the accuracy of the diagnosis, and whether sleep, medications, medical conditions, hormonal or metabolic factors, trauma, or other contributors could be affecting the response. The goal is to understand why previous treatments may not have worked before deciding what should come next.

Some can, although the likelihood and severity vary significantly by medication and individual. If a medication is helping your mental health but affecting weight, sexual function, energy, sleep, or another important part of your health, tell your prescriber. Those effects should become part of the treatment decision. Depending on the situation, your clinician may monitor the issue, adjust the dose, consider another medication, evaluate other contributors, or modify the broader treatment plan. You should not abruptly stop a psychiatric medication without discussing it with your prescriber.

Not necessarily. How long medication is appropriate depends on the condition being treated, how many previous episodes you have experienced, your response to treatment, risk of recurrence, other health factors, and your preferences. For some people, longer-term treatment provides important stability. For others, medication may eventually be reduced or discontinued under clinical supervision. If that becomes appropriate, your clinician can develop a gradual plan while continuing to monitor symptoms and the other supports that help keep you well.

Therapy is not expected to eliminate every difficult emotion immediately. Its purpose is to help you better understand patterns, process experiences, change behaviors, build new skills, strengthen relationships, and respond differently when difficult emotions arise. Progress is not always linear. Some periods of therapy may feel more challenging than others, particularly when you are working through difficult material. What matters is whether therapy is helping you move toward the goals you established over time.

Yes. Understanding why you think, feel, or behave a certain way is different from being able to change the pattern. Therapy can help turn insight into action by working on emotional processing, behavioral change, relationships, coping strategies, and practicing new responses in real situations. Being able to explain a pattern intellectually does not necessarily mean the pattern no longer affects you.

Psychological health does not exist separately from the rest of your health. Mood, anxiety, behavior, relationships, sleep, medications, hormones, physical health, and life circumstances can all influence one another. When appropriate, Fountain’s psychologists can work alongside psychiatry and other members of your care team so psychological treatment is informed by the broader clinical picture rather than occurring in isolation. Fountain’s care model is designed to bring psychological, psychiatric, medical, nutritional, and other relevant perspectives into a coordinated plan when multiple areas are involved.

There is no single correct style. Some forms of therapy are highly structured and goal-oriented, while others are more exploratory. Therapy should still feel collaborative. If you want more direction, clearer goals, more practical exercises, or more space to explore, it is appropriate to tell your therapist. A good therapeutic relationship should allow you to discuss what is and is not working about the process itself.

A strong therapeutic relationship should give you enough trust and safety to speak honestly, including about things that are uncomfortable or difficult to discuss. It can also help to ask whether your therapist has experience with the issues you want to address, what therapeutic approach they use, what the goals of treatment are, and how progress will be evaluated. The right fit does not mean every session will feel comfortable, but you should understand why you are doing the work and feel able to discuss concerns openly.

It can be. Discussing painful experiences or confronting patterns you have avoided may temporarily bring up difficult emotions. That is different from consistently leaving therapy feeling significantly worse, unsafe, or unable to function. If you feel overwhelmed, stuck, or notice that your symptoms are worsening, tell your therapist. That information can help determine whether the pace, approach, or treatment plan needs to change.

Therapy should have goals that are meaningful to you. Progress may include fewer or less intense symptoms, better emotional regulation, healthier relationships, improved functioning, greater flexibility in how you respond to stress, or changing behaviors that have been difficult to change. Not every improvement will show up immediately as “feeling happier.” Sometimes progress first looks like recognizing a pattern earlier, recovering more quickly from distress, setting better boundaries, or responding differently in situations that previously felt automatic.

There is no universal timeline. Some therapies are designed to address a specific problem over a defined period, while other people benefit from longer-term work. The appropriate duration depends on your goals, diagnosis, the type of therapy being used, the complexity of what you are working through, and whether treatment continues to provide meaningful value. Therapy should be periodically reassessed rather than continued indefinitely without asking whether it is still helping.

Mental health is influenced by more than the brain alone. Sleep, hormones, metabolism, nutrition, medications, inflammation, physical health, psychological factors, and life circumstances can all affect how someone feels and functions. At Fountain, we look across these systems when the clinical picture suggests they may be relevant. That can mean bringing together psychiatry, psychology, internal medicine, nutrition, hormonal care, sleep medicine, and biological assessment rather than treating each symptom in isolation. The goal is not to assume every mental health condition has a biological cause. It is to make sure potentially important contributors are not missed.

Yes. Thyroid disorders can produce symptoms that overlap with mental health conditions, including changes in energy, concentration, sleep, mood, and physical functioning. That does not mean thyroid disease explains most depression or anxiety. It means that when the symptoms, history, or other clinical findings suggest a possible thyroid issue, it may be worth evaluating rather than assuming every symptom is psychiatric.

They can. Hormonal changes and metabolic problems may contribute to symptoms such as fatigue, sleep disruption, changes in motivation, difficulty concentrating, changes in sexual function, or shifts in mood. These symptoms can also arise from psychiatric conditions, medications, poor sleep, nutritional deficiencies, or other medical issues. Fountain looks at the pattern as a whole and determines which factors appear clinically relevant rather than attributing symptoms to a single hormone or biomarker.

Yes. Certain nutritional deficiencies can contribute to fatigue, poor concentration, neurological symptoms, low energy, or other complaints that overlap with mental health concerns. Whether testing is appropriate depends on your symptoms, diet, medical history, medications, and other risk factors. If a deficiency is identified, correcting it may become one part of the broader treatment plan rather than being viewed as the sole explanation for how you feel.

Yes. Sleep and mental health strongly influence one another. Poor sleep can affect concentration, energy, emotional regulation, stress tolerance, and overall functioning. At the same time, depression, anxiety, trauma, medications, hormonal changes, and other conditions can disrupt sleep. Persistent sleep problems therefore deserve their own evaluation rather than automatically being treated as a secondary symptom.

Fatigue can come from many different sources, and normal basic laboratory testing does not rule out every medical, psychiatric, sleep-related, nutritional, hormonal, medication-related, or behavioral contributor. The answer is not necessarily to order every available test. The better approach is to understand the pattern of your fatigue, including when it occurs, what other symptoms accompany it, how you sleep, what medications you take, and what has already been evaluated. From there, additional testing or specialist input can be used selectively if it is likely to clarify the problem. Fountain’s broader model is specifically designed for symptoms that may sit across multiple systems rather than one clear diagnosis.

Inflammation and the immune system are being studied extensively in relation to depression and other psychiatric conditions, and there appears to be an inflammatory component in some patients. That does not mean an elevated inflammatory marker proves that inflammation is the cause of someone’s depression, or that lowering one laboratory value will necessarily resolve psychiatric symptoms. At Fountain, inflammatory markers are interpreted alongside symptoms, medical history, metabolic health, sleep, medications, and other relevant findings rather than used as a standalone explanation.

No. More testing is not automatically better care. Biological testing is most useful when it can answer a specific clinical question, identify a treatable contributor, establish a baseline, improve treatment safety, or change what we do next. Fountain’s approach is not “test everything.” It is to use the right biological information at the right time and integrate it with psychiatric, psychological, and medical care. When testing does not meaningfully inform a decision, it may not be necessary.

“Brain fog” is not a specific medical diagnosis. People use the term to describe symptoms such as difficulty concentrating, slower thinking, forgetfulness, trouble finding words, reduced mental clarity, or feeling less mentally present. Because the term can mean different things to different people, the first step is defining exactly what has changed. Someone having trouble sustaining attention may need a different evaluation from someone experiencing new memory problems or slower processing speed.

We start by determining what kind of cognitive change you are actually experiencing and what may be contributing to it. Depending on the situation, evaluation can include psychiatric symptoms, sleep, medications, substance use, hormones, metabolic health, nutritional status, medical history, and other biological factors. When appropriate, neuropsychological testing can help characterize changes in areas such as attention, memory, processing speed, or executive function. Fountain’s cognitive pathway is designed to combine psychiatric, medical, biological, and neuropsychological information rather than evaluating cognition in isolation. The goal is to understand the pattern before deciding what should be treated.

All of these can affect concentration, but the patterns are often different. Your clinician may look at when the symptoms began, whether they were present in childhood, whether they occur across different settings, how you sleep, your mood and anxiety levels, medications, substance use, medical history, and whether there are changes in memory or other cognitive abilities. Rather than assuming difficulty focusing means ADHD, we try to understand what is actually interfering with attention.

Yes. Anxiety can consume attention and mental resources, interfere with working memory, disrupt sleep, and make it harder to process or retrieve information efficiently. People may describe feeling forgetful, mentally slower, distracted, or less present when anxiety is high. At the same time, persistent cognitive symptoms should not automatically be attributed to anxiety. Fountain specifically evaluates cognitive concerns where the underlying cause may be psychiatric, medical, neurological, or another treatable contributor.

They can. Poor sleep, certain medications, hormonal changes, metabolic problems, nutritional deficiencies, substance use, and other medical conditions may all contribute to fatigue, slower thinking, or difficulty concentrating. That does not mean every episode of brain fog requires extensive laboratory testing. The clinical history should guide which contributors are plausible and which testing or specialist evaluations are actually useful.

Sometimes. The right treatment depends on what is causing the problem. Improving sleep, treating anxiety or depression, changing distracting habits or environments, exercising regularly, addressing nutritional or medical contributors, and using behavioral strategies can all improve concentration in the right circumstances. If symptoms are related to a condition such as ADHD, medication may also be an evidence-based option. The goal is not to avoid medication or default to it, but to match treatment to the underlying problem.

Neuropsychological testing is a structured assessment of how different areas of cognition are functioning. Depending on the evaluation, it can examine attention, memory, processing speed, executive function, language, and other cognitive abilities. It may be useful when cognitive symptoms are persistent, complex, worsening, or difficult to distinguish from conditions such as anxiety, depression, ADHD, or other medical issues. At Fountain, neuropsychological findings can be interpreted alongside the psychiatric and medical picture so the result becomes part of a treatment plan rather than simply a test report.

It is worth seeking evaluation when cognitive changes are persistent, worsening, noticeably different from your usual functioning, or beginning to interfere with work, relationships, or everyday tasks. A sudden or severe change in cognition, particularly if it occurs with weakness, difficulty speaking, severe headache, loss of consciousness, confusion, or other new neurological symptoms, requires more urgent medical evaluation. For more gradual changes, the goal is to understand whether the symptoms reflect sleep, mental health, medications, medical or biological factors, a cognitive disorder, or some combination of these.

Fountain is an out-of-network medical practice. We do not bill most insurance plans as an in-network provider, but patients with out-of-network benefits may be eligible for reimbursement for certain services. Our team can help you understand the reimbursement process, prepare the appropriate documentation, and, for eligible services, assist with submitting a superbill to your insurance company. The amount reimbursed depends on your individual insurance plan and cannot be guaranteed.

A superbill is an itemized medical document that includes information your insurance company may require to process an out-of-network claim, such as the provider, service performed, diagnosis code, and billing code. For eligible Fountain services, a superbill can be used to request reimbursement from an insurance plan with out-of-network benefits. A superbill does not guarantee reimbursement. Your insurer ultimately determines whether a service is covered and how much it will reimburse. Fountain’s current public materials similarly describe superbills as documentation for possible out-of-network reimbursement.

Your insurance card alone may not make this clear. The best way to know is to review your plan documents or call your insurance company and ask specifically about out-of-network benefits for the type of care you are considering. Useful questions include whether you have an out-of-network deductible, how much of it has already been met, what percentage of eligible charges the plan reimburses after the deductible, how the insurer determines its allowed amount, and whether prior authorization is required. Fountain can help guide you through what information to ask for, but your insurance company makes the final coverage determination.

For eligible services, Fountain can prepare the necessary superbill and help submit it on your behalf, so you do not have to navigate the reimbursement process entirely on your own. Your insurer may still request additional information from you or from Fountain, and reimbursement is determined by your individual plan, deductible, allowed amount, and out-of-network benefits.

There is no universal reimbursement percentage because every insurance plan is different. Your reimbursement can depend on your out-of-network deductible, whether that deductible has been met, your coinsurance, the insurer’s allowed amount for the service, and the specific terms of your plan. Two patients receiving the same service may therefore receive very different reimbursements. Fountain can provide the documentation needed to pursue reimbursement, but we cannot promise that a claim will be approved or guarantee a specific reimbursement amount.

That can happen with out-of-network claims. An insurer may request additional documentation before determining whether a service is eligible for reimbursement. When appropriate, Fountain can help provide supporting clinical or billing documentation related to the services you received. Our team can also help you understand what the insurer is requesting so you are not left trying to navigate the process entirely on your own. Your insurance company still makes the final coverage and reimbursement decision, but our goal is to make the administrative process as straightforward as possible.

What is included depends on the specific service or program you are receiving. Before beginning care, our team will explain what is included in the Fountain fee and identify any expected additional costs. Depending on your treatment plan, medications, laboratory testing, imaging, outside diagnostic testing, or other third-party services may be billed separately. We want patients to understand the expected cost of care before moving forward rather than encountering unexpected charges later.

Yes. Fountain accepts CareCredit as a financing option for eligible services, which may allow patients to spread treatment costs over time depending on their CareCredit terms and approval. Our team can also explain the expected cost of your treatment, what may be eligible for out-of-network reimbursement, and what payment options are available before you begin care.

Yes. Your medical and mental health information is protected by applicable privacy laws and Fountain’s privacy practices. Your information may be used or shared when necessary for treatment, payment, healthcare operations, and other circumstances permitted or required by law. Fountain maintains patient records in accordance with HIPAA and applicable New York law. Our goal is to protect your privacy while making sure the clinicians involved in your care have the information they need to treat you safely.

Confidentiality has important legal limits. A clinician may need to disclose information in certain situations, such as when there is an imminent risk of serious harm, suspected abuse or neglect that must be reported, or when disclosure is required by law or a valid legal process. These situations are exceptions, not the norm. If you have questions about confidentiality or what information could be shared, you can ask your clinician directly.

Fountain does not generally share your medical information with family members, partners, employers, or other third parties simply because they ask for it. With your authorization, we can coordinate with an outside psychiatrist, therapist, primary care physician, specialist, or another person involved in your care. There are limited circumstances in which information may be disclosed without authorization when permitted or required by law, particularly when safety is at risk.

When multiple Fountain clinicians are involved in your treatment, relevant information may be shared among members of your care team when needed to coordinate care safely and effectively. This is part of the benefit of coordinated care. Your psychiatrist, psychologist, medical provider, or other treating clinician should not have to work from completely disconnected pieces of your health history. At the same time, your information remains subject to medical privacy protections.

No. Telling a clinician that you have suicidal thoughts does not automatically mean you will be hospitalized. Your clinician will try to understand the severity of the situation, including whether you have intent, a plan, access to means, protective factors, and whether you are able to remain safe. The goal is to respond to the actual level of risk. Depending on the situation, that may involve additional support, a safety plan, closer follow-up, involving someone you trust with your permission when appropriate, or urgent evaluation when necessary.

Fountain provides ongoing mental health and medical care, but Fountain is not an emergency service or a substitute for an emergency department. If you are experiencing an immediate life-threatening emergency, believe you may act on thoughts of harming yourself or someone else, or are unable to remain safe, call 911 or go to the nearest emergency department. For an immediate mental health or suicide-related crisis in the United States, you can also call or text 988 for the Suicide & Crisis Lifeline.

Yes. Patients generally have the right to request access to their medical records, subject to applicable law and certain limited exceptions. If you would like a copy of your records or need them sent to another treating clinician, Fountain can explain the appropriate request process and any authorization that may be required.

There is currently no strong clinical evidence showing that NAD+ therapy reverses human aging or reliably extends lifespan. NAD+ biology is scientifically important, and increasing NAD-related metabolites has produced interesting results in laboratory and animal research. In human studies, oral NAD+ precursors such as NR and NMN can increase NAD-related biomarkers, but improvements in healthspan-related outcomes have been inconsistent. Evidence for injectable NAD+ itself is even more limited. Fountain therefore views NAD+ as a potential adjunct for selected patients, not a replacement for exercise, sleep, metabolic health, nutrition, cardiovascular risk management, and other established components of healthy aging.

No. NAD+, nicotinamide mononucleotide (NMN), and nicotinamide riboside (NR) are related but distinct compounds, and they are administered and metabolized differently. Most human research on increasing NAD+ has focused on oral precursors such as NR and NMN rather than injectable NAD+ itself. Evidence from one compound or administration route therefore cannot automatically be applied to another. Recent reviews specifically note that direct clinical outcomes data for parenteral NAD+ remain sparse.

Not in the same way that a laboratory test can diagnose something like iron deficiency or hypothyroidism. NAD+ can be measured in research and specialized laboratory settings, but there is not a widely accepted clinical NAD+ threshold that determines whether a patient should receive NAD+ therapy or predicts who will benefit from treatment. Current research also shows that the relationship between circulating NAD+ measurements, tissue NAD+ levels, aging, and clinical outcomes is still being worked out.

A plateau does not necessarily mean the medication has stopped working. As weight changes, the body’s energy needs, appetite, activity, and metabolic response can change as well. Fountain may review nutrition, physical activity, sleep, medication response, dose, body composition, adherence, other medications, and possible hormonal or metabolic contributors. The solution is not automatically a higher dose. Sometimes the right next step is a treatment adjustment, while other times the focus should shift toward body composition, strength, metabolic health, or maintaining the progress already achieved.

Weight regain is common after GLP-1-based medications are discontinued because appetite and other biological pressures that contributed to weight gain may return. That is why Fountain considers the maintenance plan from the beginning, rather than treating the medication as a short-term diet. Depending on the individual, long-term care may involve continued medication, a maintenance strategy, dose changes, or eventual discontinuation alongside nutrition, exercise, muscle preservation, sleep, and behavioral support. The appropriate approach depends on your health and response rather than assuming everyone should follow the same timeline.

No. Zepbound and Mounjaro are FDA-approved branded medications containing tirzepatide. A compounded tirzepatide product is prepared by a compounding pharmacy and is not an FDA-approved finished drug product or a generic version of Zepbound or Mounjaro. FDA does not review compounded medications for safety, effectiveness, or manufacturing quality before dispensing in the same way it reviews approved medications. When compounded medication is prescribed, pharmacy selection, formulation, dosing instructions, clinical oversight, and ongoing monitoring are therefore especially important.

Not necessarily. Tirzepatide and semaglutide are different medications, and there is no single option that is best for every patient. Semaglutide acts primarily on the GLP-1 receptor, while tirzepatide acts on both GLP-1 and GIP receptors. On average, studies have shown greater weight loss with tirzepatide in some populations, but average trial results do not determine what is best for an individual patient. Fountain considers your health history, goals, prior treatments, side effects, other medications, metabolic health, and individual response before deciding which medication is more appropriate.

No. Compounded semaglutide products are not FDA-approved finished drug products. FDA does not review compounded medications for safety, effectiveness, or manufacturing quality before they are dispensed in the same way it reviews an approved medication. FDA has also raised concerns about dosing errors and certain unapproved semaglutide formulations used in compounded products. If compounded semaglutide is prescribed, pharmacy selection, formulation, dosing instructions, and clinical monitoring are therefore particularly important.

Weight loss rarely occurs at the same rate indefinitely, and a plateau does not automatically mean that semaglutide has stopped working. Your care team may review your dose, appetite, nutrition, physical activity, body composition, sleep, adherence, other medications, and possible hormonal or metabolic contributors. Sometimes treatment should be adjusted. In other cases, the appropriate goal may shift toward maintaining weight, improving muscle mass, or continuing to improve metabolic health rather than simply pursuing additional scale loss.

Weight regain can occur after semaglutide is discontinued because appetite and other biological pressures affecting weight may return. That is why the long-term plan matters. Depending on your health and response, treatment may involve continued medication, a maintenance strategy, dose adjustments, or eventual discontinuation with continued nutrition, resistance training, physical activity, sleep, and behavioral support.

No. Growth hormone therapy provides growth hormone directly. Sermorelin instead stimulates the pituitary gland to release the body’s own growth hormone. That distinction affects how the treatment works and how it is monitored. Sermorelin also depends on the body’s ability to respond to the GHRH signal, so it is not simply an interchangeable alternative to growth hormone therapy.

A laboratory change does not automatically mean a treatment is successful. If sermorelin is being used with the goal of improving sleep, recovery, energy, body composition, or another meaningful outcome, Fountain evaluates those outcomes alongside laboratory data. If IGF-1 changes but the reason you started treatment is not improving, your clinician may reconsider the dose, look for other contributors, or determine that continuing therapy does not provide enough benefit.

Sermorelin does not permanently reset the growth hormone system. If treatment is stopped, the stimulatory effect on growth hormone release is expected to diminish, and IGF-1 may move back toward its prior level. Whether any changes in sleep, recovery, or body composition persist depends on many other factors, including exercise, nutrition, sleep, hormones, and overall health. There is also no universal rule that everyone needs to “cycle” sermorelin. Duration and discontinuation should be individualized rather than based on a generic peptide protocol.

GHK-Cu has a substantial amount of laboratory and preclinical research examining collagen, wound healing, tissue remodeling, and skin biology. The limitation is that the body of well-controlled human clinical research is much smaller. That means the biological rationale may be interesting without establishing the magnitude of benefit a particular patient should expect from a topical compounded product. Fountain therefore treats GHK-Cu as a potential adjunct for skin health rather than a proven skin-rejuvenation therapy.

Potentially, but the complete skincare routine matters. Retinoids, exfoliating acids, prescription dermatologic treatments, and other active products can already cause irritation. Adding another topical product may increase sensitivity even when the ingredients do not have a direct drug interaction. Tell your clinician what you currently use on your skin and follow the pharmacy-specific instructions for your GHK-Cu formulation. If irritation develops, the timing or frequency of one or more products may need to be adjusted.

No. Antioxidant and redox systems are tightly regulated, and health is not determined by maximizing the concentration of one antioxidant. The goal should be to address a specific clinical problem or treatment objective. Increasing a biological marker simply because it is associated with antioxidant activity does not necessarily produce a better clinical outcome.

Injectable medications bypass many of the body's normal protective barriers, which makes sterility, ingredient quality, concentration, and preparation particularly important. FDA has reported adverse events and recalls involving some compounded injectable glutathione products containing inappropriate ingredients or excessive endotoxin. That makes appropriate pharmacy sourcing an important part of treatment safety, not merely a manufacturing detail.

There is growing interest in methylene blue for cognition, mental clarity, and energy, but the evidence is still limited and results are not predictable. Some research has explored its effects on memory and brain function, but it is not established as a standard treatment for brain fog or cognitive enhancement. At Fountain, the decision to use methylene blue depends on the broader clinical picture, including what may be contributing to the symptoms in the first place and whether treatment produces a meaningful benefit over time.

Before starting methylene blue, your clinician should review your medications, supplements, medical history, and the specific reason you are considering treatment. Certain antidepressants and other medications that affect serotonin can interact with methylene blue, and some patients may also need additional safety screening depending on their medical history. The goal is to make sure methylene blue is appropriate for you and that it is being used for a clearly defined reason rather than as a general cognitive or energy supplement.

Synapsin is used by some clinicians for concerns involving mental clarity, attention, memory, and cognitive function, but direct clinical evidence for the compounded formulation is still limited. Its ingredients have been studied for roles related to cellular energy, neurological function, and inflammatory signaling, which provides a rationale for further research. That does not mean every patient with brain fog or difficulty concentrating will benefit. At Fountain, Synapsin is considered only after identifying what the patient is actually experiencing and what may be contributing to it. The treatment is then judged by whether there is a meaningful improvement in cognition or day-to-day function, not simply by whether the patient notices a sensation after using it.

Synapsin is not a stimulant and is not a substitute for established ADHD treatment. Stimulant medications act on neurotransmitter systems involved in attention and executive function and have a substantial evidence base for appropriately diagnosed ADHD. Synapsin is a compounded intranasal formulation used in a different clinical context, often when the concern is broader cognitive function, brain fog, or mental clarity. If concentration problems are actually being driven by ADHD, poor sleep, anxiety, depression, medication effects, hormonal changes, or another medical issue, that underlying problem may need to be treated directly. Fountain uses Synapsin as one potential tool within a broader cognitive evaluation rather than treating every focus complaint the same way.

No. Oxytocin participates in neural pathways involved in social behavior, but human attachment and emotional connection are far more complex than the concentration of a single hormone. Mood, relationship quality, psychological history, context, stress, sexual function, and many other factors influence how people experience connection. Calling oxytocin a “love hormone” can therefore create expectations that the science does not support.

The same symptom can have very different underlying causes. Low sexual desire, for example, may involve medications in one patient, hormonal changes in another, and stress, pain, depression, sleep, or relationship factors in someone else. Fountain evaluates the broader clinical picture because a treatment directed at one biological pathway is unlikely to produce the same result in everyone.

PT-141 is generally considered when the primary concern involves low sexual desire, reduced arousal, or decreased sexual responsiveness. Because sexual health can be affected by hormones, medications, stress, mood, sleep, relationship factors, and physical health, the first step is understanding what may be driving the change. PT-141 may be one option when its mechanism fits the specific concern.

PT-141 acts on pathways in the brain involved in sexual desire and arousal, so increased interest in or responsiveness to sexual activity is one of the reasons it may be prescribed. Response varies from person to person, and it does not create desire automatically. Fountain evaluates whether treatment is producing a meaningful change in sexual interest, arousal, and overall sexual function rather than simply whether a patient notices an immediate sensation.

That depends on what is causing the sexual concern. For example, low testosterone or estrogen, certain medications, stress, depression, poor sleep, erectile dysfunction, and relationship factors can all affect sexual function in different ways. Fountain looks at the broader picture first and then determines whether PT-141, hormonal treatment, a medication such as tadalafil, or another approach is more appropriate.

Tadalafil and sildenafil are both commonly used to treat erectile dysfunction, but they differ mainly in how long they last and how they are typically taken. Tadalafil has a longer duration of action and can be taken either as needed or as a lower daily dose. Sildenafil is generally taken closer to anticipated sexual activity. The better option depends on your preferences, medical history, other medications, side effects, and how you respond to treatment.

Tadalafil can improve erectile function, but it does not directly increase sexual desire. If low libido is the main concern, there may be other factors involved, including hormones, medications, stress, mood, sleep, relationship factors, or other medical conditions. At Fountain, we look at what is actually driving the change in sexual function rather than assuming that erectile function and sexual desire are the same problem.

It can if low testosterone is meaningfully contributing to those symptoms, but response varies. Energy, sexual function, motivation, strength, and recovery are influenced by many factors beyond testosterone. Fountain looks at whether improving testosterone actually translates into better symptoms and function rather than assuming a higher testosterone level will automatically make someone feel better.

Because testosterone may not have been the only reason you were experiencing symptoms. Fatigue, low libido, brain fog, poor recovery, and low motivation can also be influenced by sleep, stress, mental health, medications, nutrition, metabolic health, other hormones, and medical conditions. If testosterone improves but you do not feel significantly different, that is useful information and may mean the broader picture needs to be reconsidered.

The risks of estrogen therapy depend on the individual and cannot be reduced to a simple yes or no. Age, medical history, the type and route of estrogen, how long it is used, whether progesterone is also needed, and your personal cardiovascular and cancer risk all matter. Fountain reviews these factors before treatment so the decision is based on your individual balance of potential benefits and risks.

No. There is not a single age when everyone needs to discontinue estrogen therapy. Whether to continue treatment depends on your symptoms, health history, risk factors, treatment benefits, and preferences. These factors can change over time, which is why hormone therapy should be periodically reassessed rather than continued or discontinued automatically based on age alone.

Systemic estrogen circulates throughout the body and may be used for symptoms such as hot flashes and night sweats. Low-dose vaginal estrogen works primarily in the vaginal and urinary tissues and is commonly used for concerns such as vaginal dryness, irritation, discomfort during sex, and other genitourinary symptoms. Although both contain estrogen, they are used differently and are not interchangeable treatments.

Progesterone refers to the hormone naturally produced by the body and can also refer to medications that are chemically identical to it. Progestins are medications designed to produce similar effects but may differ in how they act in the body, their side-effect profiles, and how they are used clinically. Your clinician will determine which type makes the most sense based on the purpose of treatment and the rest of your hormone regimen.

Yes. When progesterone is being used alongside systemic estrogen to protect the uterine lining, the dose, route, and schedule all matter. Simply taking progesterone does not automatically mean the uterine lining is adequately protected. Fountain considers the entire estrogen and progesterone regimen together and monitors treatment based on your individual needs.

Not necessarily. Some patients remain on testosterone long term because the underlying reason for low testosterone persists, while others may eventually discontinue treatment. Because testosterone therapy can suppress the body’s own production, stopping treatment may require time for natural hormone signaling to recover. Fountain discusses the long-term plan, fertility considerations, monitoring, and potential alternatives before treatment rather than treating testosterone as a casual short-term intervention.

That usually means it is worth looking beyond testosterone. Sleep problems, stress, anxiety, depression, medications, nutrition, metabolic health, relationship factors, other hormones, and medical conditions can produce many of the same symptoms associated with low testosterone. Fountain’s goal is not simply to normalize a laboratory value. It is to understand what is contributing to how you feel and build treatment around meaningful improvement in your health and function.

Testosterone therapy should not be viewed as universally dangerous, but cardiovascular and prostate health still need to be considered before and during treatment. Your individual risk depends on factors such as your medical history, age, blood pressure, blood counts, prostate history, and other health conditions. Appropriate patient selection and ongoing monitoring are therefore an important part of testosterone treatment. Fountain evaluates these risks individually rather than assuming testosterone is either completely risk-free or inherently unsafe.